Your browser doesn't support javascript.
loading
Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy.
Mohammaden, Mahmoud H; Haussen, Diogo C; Al-Bayati, Alhamza R; Hassan, Ameer; Tekle, Wondwossen; Fifi, Johanna; Matsoukas, Stavros; Kuybu, Okkes; Gross, Bradley A; Lang, Michael J; Narayanan, Sandra; Cortez, Gustavo M; Hanel, Ricardo A; Aghaebrahim, Amin; Sauvageau, Eric; Farooqui, Mudassir; Ortega-Gutierrez, Santiago; Zevallos, Cynthia; Galecio-Castillo, Milagros; Sheth, Sunil A; Nahhas, Michael; Salazar-Marioni, Sergio; Nguyen, Thanh N; Abdalkader, Mohamad; Klein, Piers; Hafeez, Muhammad; Kan, Peter; Tanweer, Omar; Khaldi, Ahmad; Li, Hanzhou; Jumaa, Mouhammad; Zaidi, Syed; Oliver, Marion; Salem, Mohamed M; Burkhardt, Jan-Karl; Pukenas, Bryan A; Alaraj, Ali; Peng, Sophia; Kumar, Rahul; Lai, Michael; Siegler, James; Nogueira, Raul G.
Afiliação
  • Mohammaden MH; Department of Neurology, Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine-Atlanta, GA (M.H.M., D.C.H.).
  • Haussen DC; Department of Neurology, Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine-Atlanta, GA (M.H.M., D.C.H.).
  • Al-Bayati AR; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
  • Hassan A; Department of Neurology, Valley Baptist Medical Center, Harlingen, TX (A.H., W.T.).
  • Tekle W; Department of Neurology, Valley Baptist Medical Center, Harlingen, TX (A.H., W.T.).
  • Fifi J; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).
  • Matsoukas S; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).
  • Kuybu O; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
  • Gross BA; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
  • Lang MJ; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
  • Narayanan S; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
  • Cortez GM; Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).
  • Hanel RA; Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).
  • Aghaebrahim A; Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).
  • Sauvageau E; Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).
  • Farooqui M; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).
  • Ortega-Gutierrez S; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).
  • Zevallos C; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).
  • Galecio-Castillo M; Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).
  • Sheth SA; Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).
  • Nahhas M; Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).
  • Salazar-Marioni S; Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).
  • Nguyen TN; Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).
  • Abdalkader M; Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).
  • Klein P; Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).
  • Hafeez M; Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).
  • Kan P; Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).
  • Tanweer O; Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).
  • Khaldi A; Department of Neurosciences, WellStar Health System, Atlanta, GA (A.K., H.L.).
  • Li H; Department of Neurosciences, WellStar Health System, Atlanta, GA (A.K., H.L.).
  • Jumaa M; Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).
  • Zaidi S; Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).
  • Oliver M; Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).
  • Salem MM; Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).
  • Burkhardt JK; Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).
  • Pukenas BA; Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).
  • Alaraj A; Department of Neurosurgery, University of Illinois at Chicago (A.A., S.P.).
  • Peng S; Department of Neurosurgery, University of Illinois at Chicago (A.A., S.P.).
  • Kumar R; Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).
  • Lai M; Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).
  • Siegler J; Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).
  • Nogueira RG; UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).
Stroke ; 53(9): 2779-2788, 2022 09.
Article em En | MEDLINE | ID: mdl-35770672
BACKGROUND: Successful reperfusion is one of the strongest predictors of functional outcomes after mechanical thrombectomy (MT). Despite continuous advancements in MT technology and techniques, reperfusion failure still occurs in ≈15% to 30% of patients with large vessel occlusion strokes undergoing MT. We aim to evaluate the safety and efficacy of rescue intracranial stenting for large vessel occlusion stroke after failed MT. METHODS: The SAINT (Stenting and Angioplasty in Neurothrombectomy) Study is a retrospective analysis of prospectively collected data from 14 comprehensive stroke centers through January 2015 to December 2020. Patients were included if they had anterior circulation large vessel occlusion stroke due to intracranial internal carotid artery and middle cerebral artery-M1/M2 segments and failed MT. The cohort was divided into 2 groups: rescue intracranial stenting and failed recanalization (modified Thrombolysis in Cerebral Ischemia score 0-1). Propensity score matching was used to balance the 2 groups. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale at 90 days. Secondary outcomes included functional independence (90-day modified Rankin Scale score 0-2). Safety measures included symptomatic intracranial hemorrhage and 90-day mortality. RESULTS: A total of 499 patients were included in the analysis. Compared with the failed reperfusion group, rescue intracranial stenting had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 2.31 [95% CI, 1.61-3.32]; P<0.001), higher rates of functional independence (35.1% versus 7%; adjusted odds ratio [aOR], 6.33 [95% CI, 3.14-12.76]; P<0.001), and lower mortality (28% versus 46.5%; aOR, 0.55 [95% CI, 0.31-0.96]; P=0.04) at 90 days. Rates of symptomatic intracerebral hemorrhage were comparable across both groups (7.1% versus 10.2%; aOR, 0.99 [95% CI, 0.42-2.34]; P=0.98). The matched cohort analysis demonstrated similar results. Specifically, rescue intracranial stenting (n=107) had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 3.74 [95% CI, 2.16-6.57]; P<0.001), higher rates of functional independence (34.6% versus 6.5%; aOR, 10.91 [95% CI, 4.11-28.92]; P<0.001), and lower mortality (29.9% versus 43%; aOR, 0.49 [95% CI, 0.25-0.94]; P=0.03) at 90 days with similar rates of symptomatic intracerebral hemorrhage (7.5% versus 11.2%; aOR, 0.87 [95% CI, 0.31-2.42]; P=0.79) compared with patients who failed to reperfuse (n=107). There was no heterogeneity of treatment effect across the prespecified subgroups for improvement in functional outcomes. CONCLUSIONS: Acute intracranial stenting appears to be a safe and effective rescue strategy in patients with large vessel occlusion stroke who failed MT. Randomized multicenter trials are warranted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arteriopatias Oclusivas / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arteriopatias Oclusivas / Isquemia Encefálica / Acidente Vascular Cerebral Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article